Rio Grande Neurosciences Inc. develops, acquires, and licenses non-invasive brain stimulation therapies to treat pathologies of the central nervous system. The company’s portfolio includes repetitive multi-coil transcranial magnetic stimulations, targeted pulsed electromagnetic field therapies, and closed-loop transcranial electrical stimulations. It offers its therapies for patients suffering from brain trauma, psychiatric illness, and chronic neurological diseases. The company was founded in 2011 and is based in San Francisco, California.